XML 20 R13.htm IDEA: XBRL DOCUMENT
v3.25.1

Investments in Other Entities | 3 Months Ended
--- | ---
Mar. 31, 2025
Equity Method Investments and Joint Ventures [Abstract] |
Investments in Other Entities | 5. Investments in Other Entities Equity Method For the three months ended March 31, 2025 and 2024, the Company’s equity method investment activity and balance consisted of the following (in thousands):
|  | % of Ownership |  | December 31, 2024 |  |  | Initial Investment |  |  | Allocation of Net (Loss) Income |  |  | Distribution |  |  | March 31, 2025 |
LaSalle Medical Associates – IPA line of business |  | 25% |  | $ | 13,128 |  |  | $ | — |  |  | $ | (343 | ) |  | $ | — |  |  | $ | 12,785 |
Pacific Medical Imaging & Oncology Center, Inc. |  | 40% |  |  | 1,660 |  |  |  | — |  |  |  | 4 |  |  |  | — |  |  |  | 1,664 |
CAIPA MSO, LLC |  | 30% |  |  | 14,612 |  |  |  | — |  |  |  | 264 |  |  |  | — |  |  |  | 14,876 |
I Health, Inc. |  | 25% |  |  | 6,077 |  |  |  | — |  |  |  | 51 |  |  |  | — |  |  |  | 6,128 |
Other* |  | 25% - 51% |  |  | 3,842 |  |  |  | (347 | ) |  |  | (843 | ) |  |  | (100 | ) |  |  | 2,552 |
|  |  |  | $ | 39,319 |  |  | $ | (347 | ) |  | $ | (867 | ) |  | $ | (100 | ) |  | $ | 38,005 |
*Other consists of smaller equity method investments including those from the CHS acquisition.
|  | % of Ownership |  | December 31, 2023 |  |  | Initial Investment |  |  | Allocation of Net Income |  |  | Distribution |  |  | March 31, 2024 |
LaSalle Medical Associates – IPA line of business |  | 25% |  | $ | 9,866 |  |  | $ | — |  |  | $ | 359 |  |  | $ | — |  |  | $ | 10,225 |
Pacific Medical Imaging & Oncology Center, Inc. |  | 40% |  |  | 1,691 |  |  |  | — |  |  |  | 27 |  |  |  | — |  |  |  | 1,718 |
CAIPA MSO, LLC |  | 30% |  |  | 13,660 |  |  |  | — |  |  |  | 186 |  |  |  | — |  |  |  | 13,846 |
I Health, Inc. |  | 25% |  |  | — |  |  |  | 9,487 |  |  |  | — |  |  |  | — |  |  |  | 9,487 |
Other* |  | 25% |  |  | 557 |  |  |  | — |  |  |  | 60 |  |  |  | — |  |  |  | 617 |
|  |  |  | $ | 25,774 |  |  | $ | 9,487 |  |  | $ | 632 |  |  | $ | — |  |  | $ | 35,893 |
*Other consists of smaller equity method investments. The Company records its investments in certain non-consolidated VIEs within investments in other entities – equity method in the accompanying condensed consolidated balance sheets. These entities were determined to be VIEs but are not consolidated because despite providing financial support to these entities, the Company lacks a controlling financial interest and is not the primary beneficiary. Thus, these VIEs are accounted for under the equity method of accounting. The Company recognizes its share of the investee’s earnings or losses under the “hypothetical-liquidation-at-book-value” method. As of March 31, 2025, the Company’s maximum exposure to loss was $1.9 million which represents the carrying value of the Company’s investments in the non-consolidated VIEs. Equity method investments are subject to impairment evaluation. No i mpairment loss was recorded related to equity method investments for the three months ended March 31, 2025 and 2024. Investments in Privately Held Entities The Company accounts for certain equity investments using the cost basis, adjusted for observable price changes and impairments, when there is no readily determinable fair value. Observable price changes and impairments are recognized in net income. As of both March 31, 2025, and December 31, 2024, our investments in privately held entities was $8.9 million, respectively, for which a fair value is not readily determinable and we do not have significant influence. During the three months ended March 31, 2025 and 2024, there were no observable price changes to these investments.

X
- Definition Equity Method And Other Equity Investments [Text Block] + References No definition available. + Details
Name: | asth_EquityMethodAndOtherEquityInvestmentsTextBlock
Namespace Prefix: | asth_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration